Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian Culley | M | 53 | 6 years | |
| Michael Mulroy | M | 58 | 10 years | |
| Don Bailey | M | 78 | 8 years | |
| Andy Arno | M | 64 | 10 years | |
| Joshua Riggs | M | 42 | 4 years | |
| Anula Kusum Jayasuriya | M | 67 | 3 years | |
| Dipti Amin | M | 60 | 3 years | |
| James Liu | M | 29 | 3 years | |
| Neal Bradsher | M | 58 | 15 years | |
| Padma Sundar | F | - | 5 years | |
| Angus Russell | M | 68 | 10 years | |
| Louis Silverman | M | 65 | 2 years | |
| Andrew Last | M | 64 | 9 years | |
| Deborah J. Andrews | F | 66 | 10 years | |
| George Samuel | M | 43 | 3 years | |
| Jennifer Bahr-Davidson | M | - | 14 years | |
| Jill Howe | F | 48 | 2 years | |
| Ekkehard Schütz | M | - | 3 years | |
| Derek Kelaita | M | - | 5 years | |
| Frank Lanza | M | 62 | 8 years | |
| Gary S. Hogge | M | 56 | 6 years | |
| Rami Skaliter | M | 66 |
Cell Cure Neurosciences Ltd.
 Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | 7 years |
| Yuh-Min Chiang | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert W. Peabody | M | 69 | 8 years | |
| Adi Mohanty | M | 57 | 6 years | |
| Michael West | M | 71 | 16 years | |
| Cavan Redmond | M | 63 | 7 years | |
| Judith Segall | F | 70 | 29 years | |
| Pedro Lichtinger | M | 70 | 7 years | |
| Russell Skibsted | M | 65 | 4 years | |
| Andrew von Eschenbach | M | 82 | 3 years | |
| Ronald Andrews | M | 64 | 4 years | |
| Steve Cartt | M | 61 | 5 years | |
| Ryan D. Chavez | M | 48 | 3 years | |
| Edward D. Wirth | M | 59 | 6 years | |
| Henry Nordhoff | M | 82 | 1 years | |
| Peter García | M | 62 | 2 years | |
| Stephana Patton | M | - | 2 years | |
| Thomas B. Okarma | M | 78 | 2 years | |
| William Annett | M | 70 | 4 years | |
| Franklin Berger | M | 74 | 1 years | |
| Richard Towne LeBuhn | M | 59 | 5 years | |
| Chase Leavitt | M | 42 | 2 years | |
| Melinda Griffith | F | 69 | - | |
| Jennifer Carter | M | 60 | 3 years | |
| Albert Parker | M | 58 | 2 years | |
| Tony Kalajian | M | 54 | 4 years | |
| Gisela Paulsen | M | 58 | 1 years | |
| Kevin Cook | M | 53 | 1 years | |
| Gary K. Duberstein | M | - |
Greenway Partners LP
 Greenway Partners LP Investment ManagersFinance Greenway Partners LP is the hedge fund management subsidiary of Greenbelt Corp. Headquartered in New York City, the firm manages the assets of high-net-worth clients. | 8 years |
| Anish John | M | 53 | 2 years | |
| William Haack | M | - | 2 years | |
| Nat Ricciardi | M | 75 | 5 years | |
| Abraham E. Cohen | M | 86 | - | |
| David Schlachet | M | 78 | 4 years | |
| Stephen Farrell | M | 59 | 7 years | |
| Brandi Roberts | F | 50 | 2 years | |
| Arnold I. Burns | M | 94 | 4 years | |
| Mitchell Levine | M | - | - | |
| Howard I. Scher | M | 72 | 3 years | |
| Jeffrey D. Janus | M | 68 |
ES Cell International Pte Ltd.
 ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | 3 years |
| Katharine E. Spink | M | 49 | 5 years | |
| François Binette | M | - | - | |
| Moshe Hukaylo | M | - |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | - |
| Kim Dickinson | M | - | 2 years | |
| Yu Li | M | - | 1 years | |
| Andrea Park | F | 52 | 14 years | |
| Craig Halberstadt | M | - | - | |
| Alexandra Hernandez | F | - | 3 years | |
| David Jin | M | 56 | 8 years | |
| Robert N. Butler | M | 97 | 2 years | |
| Oscar Cuzzani | M | - | - | |
| Jane S. Lebkowski | M | 68 | 4 years | |
| Kristine C. Mechem | M | - | 4 years | |
| Karen B. Chapman | M | - | 6 years | |
| Lesley A. Stolz | M | 60 | 1 years | |
| Kirk Trisler | M | 64 | 1 years | |
| Georgia Erbez | F | 57 | 1 years | |
| James Knight | M | - | - | |
| Walter Funk | M | 64 | 3 years | |
| Douglas Ross | M | 64 | 2 years | |
| John Gutfreund | M | 38 | 1 years | |
| Lyssa Friedman | F | - | 4 years | |
| William K. Seltzer | M | - | - | |
| John Mauldin | M | - | - | |
| William P. Tew | M | 77 | 4 years | |
| Lyndal K. Hesterberg | M | - | 4 years | |
| Michael G. Vicari | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 86 | 97.73% |
| Israel | 2 | 2.27% |
| Singapore | 1 | 1.14% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alfred Kingsley
- Personal Network
